Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease Dementia (PDD)”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Study completedNCT00630500
What this trial is testing

Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)

Who this might be right for
Dementia Associated With Parkinson's DiseaseDementia With Lewy Bodies
Helse Stavanger HF 75
Not applicableNot Yet RecruitingNCT07114354
What this trial is testing

Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease

Who this might be right for
Dementia (Diagnosis)Parkinson Disease Dementia (PDD)Parkinson Disease (PD)
The University of Queensland 275
Testing effectiveness (Phase 2)Study completedNCT02258152
What this trial is testing

SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)

Who this might be right for
Parkinson's Disease Dementia (PDD)
Biotie Therapies Inc. 82
Large-scale testing (Phase 3)Study completedNCT00623103
What this trial is testing

Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)

Who this might be right for
Parkinson's Disease Dementia
Novartis 583
Testing effectiveness (Phase 2)Study completedNCT04764669
What this trial is testing

E2027 in Participants With Dementia With Lewy Bodies (DLB) or Parkinson's Disease Dementia (PDD) With or Without Amyloid Copathology

Who this might be right for
Lewy Body DiseaseParkinson Disease
Eisai Inc. 34
Early research (Phase 1)WithdrawnNCT03938922
What this trial is testing

Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia

Who this might be right for
Parkinson DiseaseDementia
Enterin Inc.
Testing effectiveness (Phase 2)Study completedNCT02708186
What this trial is testing

Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)

Who this might be right for
Dementia With Lewy BodiesREM Sleep Behavior DisorderParkinson's Disease Dementia
Axovant Sciences Ltd. 34
Post-approval studies (Phase 4)Study completedNCT00988117
What this trial is testing

The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems

Who this might be right for
Parkinsons Disease With DementiaParkinsons Disease With Mild to Moderate Memory and/or Thinking Problems
University of California, San Francisco 15
Not applicableStudy completedNCT03687203
What this trial is testing

Cognitive-driven ADL Impairment as a Predictor for PDD

Who this might be right for
Parkinson Disease
University Hospital Tuebingen 182